Cellectar Biosciences Inc (CLRB) stock has gained 111.73% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives CLRB stock a score of 89 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 98. CLRB's rank also includes a short-term technical score of 90. CLRB has an Overall Score of 89. Find out what this means to you and get the rest of the rankings on CLRB!